Cannabis Law Report

JUNE 16, 2022

According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Program Statistical Report, agents and their partners confiscated approximately 5.53 The totals are the highest reported by the agency since 2011, when it reported making an estimated 8,500 marijuana-related arrests and seized some 6.7

DEA 52

DEA Marijuana Programs Data 52

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. The MDMA Therapy Training Program was created to train the next generation of psychedelic therapists. Lyle Craker, Ph.D., million in the form of a bequest.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

SEPTEMBER 23, 2019

Surveying marijuana use is essential to gauge public health implications of increased access to marijuana, cannabinoid, and cannabis products. Due to the Schedule I classification by the Drug Enforcement Agency (DEA), researchers seeking to investigate health effects associated with cannabis must follow a regimented application process.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

The Herb Collective

JUNE 25, 2018

Surveys conducted in recent years suggest that the public approval of medical marijuana has increased, and remain above 77% since 2011. "Every year, about 98% of all of the grass removed by the DEA's "Domestic Cannabis Eradication/Suppression Program" is really hemp." Source: Cannabisser, Washington Post) 11.

Marijuana 56

Marijuana Edibles Recreational Strains 56

The Cannigma

FEBRUARY 16, 2022

So, with that, we should get into it, but don’t forget to check out our segment with Americans for Safe Access. We always have a nice little tidbit when we’re all about advocacy and access to cannabis for all. One cohort is specializing in essentially a reentry program. Let’s listen to Steven. SEGMENT START].

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73

Cannabis Law Report

MARCH 25, 2019

In 2011, Reps. The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. But DEA regulators determined after both of those reviews that marijuana should remain a Schedule I substance. Similar bills have been introduced perennially since then, most recently by Rep.

Banking 45

Banking Law Marijuana State Laws 45